AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22315765
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ketamine 2.5 mg kg(‐1) and midazolam 0.25 mg kg(‐1)
Trial: 19700035
Drug: Chapatis containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chapatis containing 4 g beta-glucan
Trial: 19700035
Drug: Control chapatis
RxNorm normalized name: hepatitis A virus strain CR 326F antigen, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control chapatis (0 g beta-glucan)
Trial: 17122236
Drug: Single Shot
RxNorm normalized name: ACL7 SINGLE SHOT EPIDURAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single Shot Spinal (SSS) with 2 mL of 0.5% hyperbaric bupivacaine
Trial: 17122236
Drug: Combined Spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Spinal Epidural (CSE) with equivalent dose of hyperbaric bupivacaine
Trial: 9727573
Drug: ZDV-3TC (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZDV-3TC (200 mg three times daily and 150 mg twice daily)
Trial: 9727573
Drug: d4T-3TC (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d4T-3TC (40 mg and 150 mg, both twice daily)
Trial: 9727573
Drug: Indinavir added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir added to both groups if plasma HIV RNA level at week 8 or thereafter was > 500 copies/ml
Trial: 26123989
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine supplementation (10 g/day for 3 or 6 months)
Trial: 26123989
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of L-arginine (0.5 g Arg/kg bodyweight for 30 min)
Trial: 23616509
Drug: Isoflavone supplement
RxNorm normalized name: Soyrel Soy Isoflavone Supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone supplement (rich in daidzein, 60%) providing 94 mg isoflavones daily for 8 weeks
Trial: 9130215
Drug: Inpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient treatment according to ASAM criteria
Trial: 9130215
Drug: Intensive outpatient
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive outpatient treatment according to ASAM criteria
Trial: 9130215
Drug: Intensive outpatient
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive outpatient treatment for alcohol patients who met ASAM criteria
Trial: 21521545
Drug: LcS-fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LcS-fermented milk administered (n 39)
Trial: 21521545
Drug: Non-administered group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-administered group (n 38)
Trial: 21521545
Drug: LcS-fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LcS-fermented milk administered (n 10)
Trial: 18356827
Drug: Catechin group
RxNorm normalized name: catechin
DrugBank: Cianidanol (DB14086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Catechin group (576 mg catechins per day)
Trial: 18356827
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (75 mg catechins per day)
Trial: 16485702
Drug: Injection over
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection over longer times (5, 10, 15, or 20 sec)
Trial: 12399900
Drug: Gastroenterology treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastroenterology treatment for patients with positive endoscopy findings
Trial: 10720164
Drug: Rye bread
RxNorm normalized name: Rye
DrugBank: Rye (DB10564)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rye bread (20% of daily energy)
Trial: 10720164
Drug: Wheat bread
RxNorm normalized name: Nutritional Supplement Oral Food, Solid [DIETARY SPECIALTIES WHEAT BREAD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bread (20% of daily energy)
Trial: 8604444
Drug: Antiarrhythmic drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drugs (sotalol or amiodarone)
Trial: 12584835
Drug: Si' an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Si' an capsule combined Enalapril
Trial: 10359467
Drug: Cortisol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol treatment (40 mg/d)
Trial: 10359467
Drug: Cortisol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol treatment (160 mg/d)
Trial: 7481854
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of paclitaxel and doxorubicin
Trial: 14521803
Drug: Single-agent paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Single-agent paclitaxel
Trial: 19045968
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive therapy (CT)
Trial: 28629905
Drug: Continuing antirheumatic
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing antirheumatic drug therapy
Trial: 28629905
Drug: Withholding antirheumatic
RxNorm normalized name: ANTIRHEUMATICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withholding antirheumatic drug therapy
Trial: 28629905
Drug: Restarting antirheumatic
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Restarting antirheumatic medications post-surgery
Trial: 24385407
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin (100-300 mg/day)
Trial: 19387336
Drug: Interactive Spaced
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interactive Spaced Education (ISE) on staghorn calculi, infertility, and antibiotic use (SIA)
Trial: 17322151
Drug: Valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80 to 160 mg once or twice daily)
Trial: 26427036
Drug: Probiotic tablet
RxNorm normalized name: Acidophilus Probiotic Tablet
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic tablet containing Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145, used twice a day for 12 weeks
Trial: 20533245
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) supplementation (159 mg/day total catechins)
Trial: 18835479
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (CBT) with integrated emotion-regulation training
Trial: 15865915
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (CBT)
Trial: 16633780
Drug: Target blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target blood propofol concentration of 6 microg x ml(‐1) (group 2)
Trial: 11213884
Drug: Rosiglitazone 2
RxNorm normalized name: rosiglitazone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 2 mg twice daily
Trial: 15089784
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg twice daily
Trial: 10768088
Drug: Rosiglitazone 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 6 mg twice daily
Trial: 11213884
Drug: Rosiglitazone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (all doses)
Trial: 8101583
Drug: Intra-articular naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular naloxone (0.04 mg)
Trial: 8101583
Drug: Intravenous naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous naloxone (0.04 mg)
Trial: 24444428
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and laser treatment (810 nm diode laser using the 'hot tip' technique at ∼ 760 °C)
Trial: 24444428
Drug: SRP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP treatment alone
Trial: 18240282
Drug: VSL#3 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VSL#3 (2 sachets once daily for 12 months)
Trial: 15731606
Drug: Intrathecal levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal levobupivacaine and ropivacaine at doses of 2.5 mg or greater
Trial: 797067
Drug: Xenon-arc photocoagulation
RxNorm normalized name: xenon
DrugBank: Xenon (DB13453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenon-arc photocoagulation treatment
Trial: 24240315
Drug: Deep neuromuscular
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep neuromuscular block (post-tetanic count 1-2) using high-dose rocuronium
Trial: 16154486
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg once daily for 8 weeks
Trial: 16154486
Drug: Pitavastatin 2
RxNorm normalized name: PITAVASTATIN 2MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 2 mg once daily for 8 weeks
Trial: 2576203
Drug: Transdermal mepindolol
RxNorm normalized name: mepindolol
DrugBank: Mepindolol (DB13530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal mepindolol (BIO TSD)
Trial: 58197
Drug: 3000 units
RxNorm normalized name: lactase 3000 units oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 units of vitamin D2 in a capsule weekly
Trial: 31059177
Drug: Progesterone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (200 mg twice daily)
Trial: 21608215
Drug: Bushen Qiangdu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bushen Qiangdu Recipe (BSQDR), one dose daily, taken in two portions (morning and evening) for six months.
Trial: 17082466
Drug: Seizure free
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seizure free (SF) group, treated with 0 to 3 antiepileptic drugs (AEDs)
Trial: 10393137
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium diet (502 +/‐ 99 mg)
Trial: 2071884
Drug: Temazepam capsule
RxNorm normalized name: Temazepam Capsules
DrugBank: Temazepam acetate (DB14671)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Temazepam capsule (20 mg)
Trial: 12124949
Drug: IntraCoil stent
RxNorm normalized name: castor fiber scent gland secretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IntraCoil stent treatment
Trial: 7486100
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg i.v. bolus followed by continuous infusion of 5 mg/h for 24 h
Trial: 17532826
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (200,000 IU single dose)
Trial: 12240794
Drug: 36 mg
RxNorm normalized name: pyrantel 136 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 36 mg CONCERTA (methylphenidate HCI) after a high-fat breakfast
Trial: 12240794
Drug: 36 mg
RxNorm normalized name: pyrantel 136 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 36 mg CONCERTA (methylphenidate HCI) after an overnight fast
Trial: 12240794
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ADDERALL XR (mixed amphetamine salts) after an overnight fast
Trial: 8673477
Drug: rIFN‐gamma therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN‐gamma therapy
Trial: 10677386
Drug: C-peptide infusion
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-peptide infusion
Trial: 21731866
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times a day
Trial: 7810176
Drug: Tryptophan supplemented
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tryptophan supplemented diet (standard diet + 1.5 g tryptophan)
Trial: 23129048
Drug: JTK-853 (800,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTK-853 (800, 1,200, or 1,600 mg twice daily or 1,200 mg three times daily)
Trial: 18929284
Drug: Dexmedetomidine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (bolus dose of 1 microg kg(‐1) and maintenance of 0.7 microg kg(‐1) hour(‐1))
Trial: 16470820
Drug: Megestrol 160
RxNorm normalized name: megestrol acetate 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megestrol 160 mg
Trial: 11604980
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (30 minutes)
Trial: 10433305
Drug: Mild hypothermia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild hypothermia therapy (intracranial temperature 34 degrees C) for 48 hours followed by rewarming at 1 degree C per day for 3 days
Trial: 10433305
Drug: Normothermia therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normothermia therapy (intracranial temperature 37 degrees C) for 5 days
Trial: 10433305
Drug: Normothermia therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normothermia therapy
Trial: 2720131
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered ibuprofen solution
Trial: 17515464
Drug: BNP >
RxNorm normalized name: Brain natriuretic peptide
DrugBank: .gamma.-brain natriuretic peptide (DB19026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNP > or = 550 pg/mL
Trial: 17515464
Drug: BNP <
RxNorm normalized name: Nesiritide
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BNP < 550 pg/mL
Trial: 17515464
Drug: BNP >
RxNorm normalized name: Brain natriuretic peptide
DrugBank: .gamma.-brain natriuretic peptide (DB19026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNP > or = 550 pg/mL in patients who underwent valve replacement
Trial: 17515464
Drug: BNP <
RxNorm normalized name: Nesiritide
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BNP < 550 pg/mL in patients who underwent valve replacement
Trial: 15155424
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg methylprednisolone acetate mixed with a short acting local anaesthetic
Trial: 2955688
Drug: Reperfusion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfusion therapy within 2 hours of symptom onset
Trial: 2955688
Drug: Reperfusion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfusion therapy within 3 hours of symptom onset
Trial: 20435181
Drug: Aspirin <150/180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin <150/180 pills/y
Trial: 20435181
Drug: Aspirin >150/180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin >150/180 pills/y and NSAID users <60 days/y
Trial: 20435181
Drug: Aspirin <150/180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin <150/180 pills/y and NSAID users >60 days/y
Trial: 15191344
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg bisoprolol given orally
Trial: 3103414
Drug: Submaintenance infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Submaintenance infusion (1.02 +/- 0.04 times fasting M, n = 6)
Trial: 3103414
Drug: Maintenance infusion
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance infusion (1.39 +/- 0.01 times fasting M, n = 20)
Trial: 17853755
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment group (Yingxiang (LI 20), Shangyingxiang (EX‐HN 8), Yintang (EX‐HN 3), Hegu (LI 4), Fengchi (GB 20), Dazhui (GV 14), Feishu (BL 13))
Trial: 17853755
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group II (oral administration of Biyankang tablets, 4 tablets each time, thrice each day)
Trial: 11772242
Drug: Ertapenem at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem at 2 mg/kg
Trial: 11772242
Drug: Imipenem at
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem at 2 mg/kg
Trial: 9389782
Drug: Peroral oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral oestrogen (2 mg oestradiol valerate tablets)
Trial: 18435668
Drug: Sulphonylurea therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulphonylurea therapy
Trial: 24996592
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise treatment (both experiments)
Trial: 22814420
Drug: Aspirin challenge
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin challenge (placebo-controlled)
Trial: 19031508
Drug: Alendronate 5
RxNorm normalized name: ALENDRONATE 5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 5 mg/day with alfacalcidol 1 microg/day
Trial: 16000354
Drug: Anagrelide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anagrelide plus low-dose aspirin
Trial: 12197051
Drug: Comparison with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison with another vaccine
Trial: 10425010
Drug: Titration group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration group (n = 20) received protamine doses based on heparin concentration measured by the Hepcon system.
Trial: 10425010
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 14) received a fixed dose of protamine (3 mg/kg).
Trial: 10425010
Drug: Titration group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration group (n = 20)
Trial: 7478713
Drug: MOR-L (11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOR-L (11 min)
Trial: 7478713
Drug: FEN-L (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEN-L (8 min)
Trial: 7478713
Drug: Lockout intervals
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lockout intervals (L and S)
Trial: 1904749
Drug: Racemic ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Racemic ibuprofen 200 mg
Trial: 1904749
Drug: Racemic ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Racemic ibuprofen 800 mg
Trial: 21128873
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and Sertraline
Trial: 17911873
Drug: Guided dosing
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided dosing within a computerized provider order entry (CPOE) system
Trial: 17911873
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no guided dosing)
Trial: 17911873
Drug: Guided dosing
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided dosing within a CPOE system
Trial: 15329426
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus recombinant surfactant protein C-based surfactant
Trial: 11583188
Drug: Targeted intra-operative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted intra-operative radiotherapy (Targit), delivered doses of 5-20 Gy over about 22 min
Trial: 9820298
Drug: Computer-generated dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-generated dosing (n=137)
Trial: 9820298
Drug: Traditional dosing
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dosing (n=148)